Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease worldwide, characterized by progressive glomerular basement membrane thickening, renal interstitial inflammation, and fibrosis. However, the molecular remodeling that drives DKD pathogenesis and differentiates diseased kidneys from healthy donor tissue remains incompletely understood.